CCM
AMPH icon

Cadence Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Cadence Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-27,593
Closed -$517K – 675
2018
Q1 		$517K Buy
27,593
+2,908
+12% +$54.7K 0.03% 500
2017
Q4 		$475K Buy
24,685
+1,782
+8% +$33.3K 0.03% 506
2017
Q3 		$409K Sell
22,903
-16,265
-42% -$268K 0.03% 539
2017
Q2 		$700K Sell
39,168
-23,619
-38% -$375K 0.05% 438
2017
Q1 		$910K Buy
62,787
+38,303
+156% +$602K 0.06% 380
2016
Q4 		$451K Buy
24,484
+544
+2% +$10.6K 0.03% 533
2016
Q3 		$454K Buy
+23,940
New +$435K 0.03% 500

Other funds holding AMPH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return